These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 12687750

  • 1. Relapse in the skull after myeloablative therapy for high-risk neuroblastoma.
    Sangthawan D, DesRosiers PM, Randall ME, Robertson K, Goebel S, Fallon R.
    Pediatr Hematol Oncol; 2003; 20(1):23-30. PubMed ID: 12687750
    [Abstract] [Full Text] [Related]

  • 2. Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor-prognosis solid tumors - Bulgarian experience.
    Avramova B, Jordanova M, Michailov G, Konstantinov D, Christosova I, Bobev D.
    J BUON; 2006; 11(4):433-8. PubMed ID: 17309174
    [Abstract] [Full Text] [Related]

  • 3. High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update.
    George RE, Li S, Medeiros-Nancarrow C, Neuberg D, Marcus K, Shamberger RC, Pulsipher M, Grupp SA, Diller L.
    J Clin Oncol; 2006 Jun 20; 24(18):2891-6. PubMed ID: 16782928
    [Abstract] [Full Text] [Related]

  • 4. A novel intensive induction therapy for high-risk neuroblastoma utilizing sequential peripheral blood stem cell collection and infusion as hematopoietic support.
    Pradhan KR, Johnson CS, Vik TA, Sender LS, Kreissman SG.
    Pediatr Blood Cancer; 2006 Jun 20; 46(7):793-802. PubMed ID: 16206215
    [Abstract] [Full Text] [Related]

  • 5. Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma.
    Bradfield SM, Douglas JG, Hawkins DS, Sanders JE, Park JR.
    Cancer; 2004 Mar 15; 100(6):1268-75. PubMed ID: 15022296
    [Abstract] [Full Text] [Related]

  • 6. CNS recurrence following CD34+ peripheral blood stem cell transplantation in stage 4 neuroblastoma.
    Choi HS, Koh SH, Park ES, Shin HY, Ahn HS.
    Pediatr Blood Cancer; 2005 Jul 15; 45(1):68-71. PubMed ID: 15770641
    [Abstract] [Full Text] [Related]

  • 7. [Long-term effect of high dose chemotherapy combined with stem cell transplantation on stage IV neuroblastoma in children].
    Tang SQ, Huang DS, Wang JW, Feng C, Yang G.
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr 15; 8(2):93-6. PubMed ID: 16613697
    [Abstract] [Full Text] [Related]

  • 8. Aggressive surgical therapy and radiotherapy for patients with high-risk neuroblastoma treated with rapid sequence tandem transplant.
    von Allmen D, Grupp S, Diller L, Marcus K, Ecklund K, Meyer J, Shamberger RC.
    J Pediatr Surg; 2005 Jun 15; 40(6):936-41; discussion 941. PubMed ID: 15991174
    [Abstract] [Full Text] [Related]

  • 9. Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study.
    Matthay KK, Tan JC, Villablanca JG, Yanik GA, Veatch J, Franc B, Twomey E, Horn B, Reynolds CP, Groshen S, Seeger RC, Maris JM.
    J Clin Oncol; 2006 Jan 20; 24(3):500-6. PubMed ID: 16421427
    [Abstract] [Full Text] [Related]

  • 10. Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapy.
    Anderson CP, Reynolds CP.
    Bone Marrow Transplant; 2002 Aug 20; 30(3):135-40. PubMed ID: 12189530
    [Abstract] [Full Text] [Related]

  • 11. Topotecan, thiotepa, and carboplatin for neuroblastoma: failure to prevent relapse in the central nervous system.
    Kushner BH, Kramer K, Modak S, Kernan NA, Reich LM, Danis K, Cheung NK.
    Bone Marrow Transplant; 2006 Feb 20; 37(3):271-6. PubMed ID: 16400336
    [Abstract] [Full Text] [Related]

  • 12. Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma?
    Al-Faris N, Al Harbi T, Goia C, Pappo A, Doyle J, Gassas A.
    Pediatr Blood Cancer; 2007 Aug 20; 49(2):190-5. PubMed ID: 17262797
    [Abstract] [Full Text] [Related]

  • 13. High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: an effective regimen with low morbidity and mortality.
    Wadhwa PD, Fu P, Koc ON, Cooper BW, Fox RM, Creger RJ, Bajor DL, Bedi T, Laughlin MJ, Payne J, Gerson SL, Lazarus HM.
    Biol Blood Marrow Transplant; 2005 Jan 20; 11(1):13-22. PubMed ID: 15625540
    [Abstract] [Full Text] [Related]

  • 14. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    Massimino M, Gandola L, Spreafico F, Biassoni V, Luksch R, Collini P, Solero CN, Simonetti F, Pignoli E, Cefalo G, Poggi G, Modena P, Mariani L, Potepan P, Podda M, Casanova M, Pecori E, Acerno S, Ferrari A, Terenziani M, Meazza C, Polastri D, Ravagnani F, Fossati-Bellani F.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1358-63. PubMed ID: 19019566
    [Abstract] [Full Text] [Related]

  • 15. Primary tumor control in patients with stage 3/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants.
    Marcus KJ, Shamberger R, Litman H, von Allmen D, Grupp SA, Nancarrow CM, Goldwein J, Grier HE, Diller L.
    J Pediatr Hematol Oncol; 2003 Dec 01; 25(12):934-40. PubMed ID: 14663275
    [Abstract] [Full Text] [Related]

  • 16. Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue.
    Zacharoulis S, Levy A, Chi SN, Gardner S, Rosenblum M, Miller DC, Dunkel I, Diez B, Sposto R, Ji L, Asgharzadeh S, Hukin J, Belasco J, Dubowy R, Kellie S, Termuhlen A, Finlay J.
    Pediatr Blood Cancer; 2007 Jul 01; 49(1):34-40. PubMed ID: 16874765
    [Abstract] [Full Text] [Related]

  • 17. Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age.
    de Kraker J, Hoefnagel KA, Verschuur AC, van Eck B, van Santen HM, Caron HN.
    Eur J Cancer; 2008 Mar 01; 44(4):551-6. PubMed ID: 18267358
    [Abstract] [Full Text] [Related]

  • 18. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
    Schmidt ML, Lal A, Seeger RC, Maris JM, Shimada H, O'Leary M, Gerbing RB, Matthay KK.
    J Clin Oncol; 2005 Sep 20; 23(27):6474-80. PubMed ID: 16116154
    [Abstract] [Full Text] [Related]

  • 19. Cyclophosphamide, etoposide and carboplatine plus non-cryopreserved autologous peripheral blood stem cell transplantation rescue for patients with refractory or relapsed non-Hodgkin's lymphomas.
    Mabed M, Al-Kgodary T.
    Bone Marrow Transplant; 2006 Apr 20; 37(8):739-43. PubMed ID: 16501587
    [Abstract] [Full Text] [Related]

  • 20. Improved survival of children with advanced neuroblastoma treated by intensified therapy including myeloablative chemotherapy with stem cell transplantation: a retrospective analysis from the Tohoku Neuroblastoma Study Group.
    Imaizumi M, Watanabe A, Kikuta A, Takano T, Ito E, Shimizu T, Tsuchiya S, Iinuma K, Konno T, Ohi R, Hayashi Y, Tohoku Neuroblastoma Study Group.
    Tohoku J Exp Med; 2001 Oct 20; 195(2):73-83. PubMed ID: 11846211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.